SEP 03, 2018 06:00 AM PDT

Insulin Boosts the Immune System

The pancreas secretes insulin, a naturally occurring hormone, that is essential for the human body. Individuals with diabetes are prescribed insulin due to non-production or improper use of insulin by the body, known as type 1 and type 2 diabetes respectively. T cells are active participants in our immune response and critical effectors of cell-mediated immunity; they play a pivotal role in self-defense against infections. But what relation does insulin play when it comes to the immune system?

Previous research has focused on the role of insulin in organs such as the liver, or in muscle and fat regulation, but little has been studied on the impact of insulin on the immune system. People with type 2 diabetes who are obese, or those at risk for developing type 2 diabetes, do not respond well or are resistant to insulin. It is also known that obesity linked to insulin resistance in humans and mice results in weakened immune responses and increased susceptibility to developing a severe infection. Two labs, the Winer Labs, demonstrated that immune cells inside abdominal fat stimulate the release of pro-inflammatory chemicals which contributes to the bodies impaired sensitivity to insulin. These results led researchers to study the link between insulin and the immune response further.

A recent study published in Cell Metabolism, by Dr. Sue Tsai, postdoctoral fellow, and senior authors Dr. Daniel Winer, Anatomical Pathologist at University Health Network and Toronto General Hospital Research Institute and Dr. Shawn Winer, Anatomical Pathologist at St. Michael’s Hospital sought to elucidate the insulin and immune system relationship. These researchers wanted to study how insulin regulates T cell function and what causes T cells to stop responding to insulin. The study utilized genetically engineered mice that had T cells lacking an insulin receptor to mimic insulin resistance. The mice were then exposed to different stressors such as the H1N1 influenza virus; researchers observed what effect these stressors had on the insulin resistant T cells.

When fighting infection T cells receive signals to boost their activation when encountering a foreign invader, the insulin receptor on the cell that interacts with a signaling molecule is a second push to bolster the immune response to foreign invaders. When the insulin receptor is non-functional, this boost isn’t present and the T cells fail to destroy viruses such as H1N1 influenza. This specific insulin signaling pathway revs up the immune response when activated by promoting T cell division and secretion of chemical messenger proteins that activate the rest of the immune system.

Future studies will focus on harnessing the insulin signaling pathway to boost the immune response to create vaccines or dampen the reaction in the case of inflammatory illnesses such as arthritis. "T cells are at the heart of so many diseases," says Dr. Tsai, "If we can understand them at the cellular level, this will give us the best opportunity to find new pathways to target for new therapies." 

To learn more about diabetes and insulin resistance watch the video below!

Sources: University Health Network, Cell Metabolism, American Diabetes Association

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
JUL 15, 2018
Immunology
JUL 15, 2018
Enzyme Pathway Mediates Immune Response to Chagas Disease
The enzyme, PI3Kγ, regulates the immune response to T. cruzi, the cause of Chagas Disease. Manipulation of this enzyme may lead to better treatment of T. cruzi....
JUL 25, 2018
Immunology
JUL 25, 2018
T Cell Response to Ebola Virus Proteins
Killer T cells of Ebola survivors respond better to nucleoproteins, not glycoproteins, potentially influencing Ebola vaccine development....
AUG 08, 2018
Immunology
AUG 08, 2018
Doxorubicin Causes Heart Toxicity by Immune System Disruption
Chemotherapy drug Doxorubicin disrupts metabolism that controls immune responses in the heart leading to heart toxicity....
AUG 10, 2018
Immunology
AUG 10, 2018
Cancer Cell 'Drones' Battle Immune System
Cancer cells release PD-L1 containing exosomes that circulate in the blood and stop T cells before they can reach tumors....
OCT 14, 2018
Immunology
OCT 14, 2018
The Stem of Cancer
Scientists reveal a pathway involved in cancer cell ability to act as stem cells...
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
Loading Comments...